Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 1

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT05685745Recruiting

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

Role: collaborator

NCT06895746Active Not Recruiting

Multi-omics Study in Citrin Deficiency

Role: collaborator

NCT02256618Phase 1Completed

Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy

Role: collaborator

NCT02455830Unknown

Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy

Role: collaborator

NCT01166152Not ApplicableUnknown

Development of a New Diagnosis and Intervention Method for Developmental Disorders

Role: collaborator

NCT01270035Phase 4Unknown

Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate

Role: collaborator

NCT00716248Phase 4Unknown

Bucillamine Study of Holding Remission After Infliximab Dose-off

Role: lead

NCT00679978Completed

Vertebral Fracture and Osteonecrosis Associated With High-dose Glucocorticoid

Role: lead

NCT00892372Completed

Relationship Between Body Weight and Glycohemoglobin

Role: lead

NCT00530595Not ApplicableCompleted

Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

Role: lead

NCT00288717Not ApplicableUnknown

Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients

Role: lead

All 11 trials loaded